Shares of Rocket Lab surged 6.5% to $67.20 after the company announced a 20-launch agreement with Japan's Synspective — its largest commercial contract ever for its small Electron rocket — while Citi simultaneously initiated coverage with a Buy rating and a $105 price target. The twin catalysts arrived at a moment when Wall Street is pricing Rocket Lab less like a launch provider and more like a vertically integrated space conglomerate.

• A Single Customer Now Accounts for 47 Missions

Synspective now holds 47 total Electron missions with Rocket Lab, exceeding any other customer. That concentration matters: the deal stretches from 2028 through 2031 and adds years of scheduled flights, giving Rocket Lab revenue visibility deep into the next decade. But dependence on one Japanese radar-satellite firm for nearly half its launch manifest introduces execution risk if Synspective's own funding or constellation plans stumble.

• The Dollar Value Is Modest Relative to the Stock Move

Rocket Lab charges around $7.5 million per Electron launch, which would give the 20-mission contract roughly a $150 million sticker price before any bulk discounting. Against a market capitalization of roughly $42 billion, that is barely a rounding error. Financial terms were not disclosed. The real signal is demand: the deal pushes Rocket Lab's launch backlog beyond 100 missions, up from over 70 just last quarter.

• Wall Street Sees 50%-Plus Upside, but the Valuation Is Stretched

Citi analyst John Godyn set a price target of $105, implying roughly 51% upside, calling Rocket Lab a "core holding for space bulls." Yet its price-to-sales ratio of 54.46x is markedly higher than its own historical median of 18.54x.

With trailing earnings per share of negative $0.28, traditional valuation metrics don't apply, leaving investors to bet on a future that includes the pending $8 billion Iridium acquisition and Neutron, its larger reusable rocket still in development.

• The Bigger Story Is Backlog Momentum, Not One Contract

Q2 revenue hit a record $234 million — up 62% year-over-year — while backlog reached $2.36 billion, a 137% annual increase.

Rocket Lab secured more than $437 million in new launch contracts during Q2 and post-quarter signings alone. The Synspective deal confirms the trend but doesn't transform the math. Investors are paying for the company Rocket Lab is becoming — not the one it is today.